Zoetis | ZTS - Net Income

Stock Price
128.95
Daily Change
0.29 0.23%
Monthly
4.06%
Yearly
-21.84%
Q1 Forecast
124.79

Zoetis reported $603M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
AbbVie USD 1.82B 1.63B Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bayer EUR -963M 764M Sep/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Coherus Biosciences USD -56.57M 5.87M Mar/2025
Dentsply International USD -427M 382M Sep/2025
Eli Lilly USD 6.64B 1.05B Dec/2025
Henry Schein USD 101M 0 Dec/2025
Idexx Laboratories USD 248.19M 26.42M Dec/2025
Illumina USD 334M 184M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
J&J USD 5.12B 36M Dec/2025
Laboratory Of America USD 164.7M 96.4M Dec/2025
Merck USD 2.96B 2.82B Dec/2025
Neogen USD -15.92M 52.26M Sep/2025
Pacira USD 5.43M 10.28M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Phibro Animal Health USD 3.18M 3.79M Dec/2024
Quest Diagnostics USD 245M 0 Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Zoetis USD 603M 118M Dec/2025